一个用于快速但严格评估随机对照试验质量的系统
Eric G Smith, Hannah L Grigorian1
1From the VA Bedford Healthcare System, Bedford, MA.
Journal of clinical psychopharmacology
|June 28, 2023
概括
国际清算局的FOES系统提供了一种7个标准的方法,可以快速准确地评估随机对照试验 (RCT). 该框架有助于医疗保健专业人员和公众评估试验质量.
科学领域:
- 临床试验方法论 临床试验方法论
- 基于证据的医学 基于证据的医学
- 研究质量评估研究质量评估
背景情况:
- 评估随机对照试验 (RCT) 的质量对于基于证据的实践至关重要.
- 现有的RCT质量评估方法可能耗时或缺乏全面性.
- 需要一个快速而又严格的系统来评估RCT.
研究的目的:
- 介绍和描述BIS FOES系统用于评估RCT质量.
- 提供一个结构化的框架来评估RCT的关键方面.
- 授权医疗保健学员,临床医生,研究人员和公众批判性地评估RCT.
主要方法:
- 国际清算局FOES系统包括7个标准:盲目化,治疗意图分析,大小 (和随机化有效性),后续 (样本损失),结果 (措施),影响 (报告发现) 和特殊考虑.
- 解释了每个标准的重要性和评估方法.
- 提供了从RCT摘要和完整文章评估标准的指导.
主要成果:
- 国际清算局的FOES系统提供了一种系统的方法来评估RCT质量.
- 该系统涵盖了RCT设计和报告的基本方面.
- 它允许从摘要进行初步评估,并在完整的文章中进行详细审查.
结论:
- BIS FOES系统能够快速,彻底地评估RCT的质量.
- 这一框架可以提高各种受众的批判性评估技能,包括医疗保健学员和研究人员.
- 有效使用BIS FOES促进了对RCT证据的更好理解和应用.
更多相关视频
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.1K
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Randomized Experiments
7.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
7.1K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Hazard Ratio
166
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
166
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
